We are live on
!
Find out more
RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$9.44B
1-Year Est. Return
68.42%
This Fund
S&P 500
This Quarter
Est. Return
-25.13%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$808M
AUM Growth
-$138M
(-15%)
Cap. Flow
+$114M
Cap. Flow
% of AUM
14.08%
Top 10 Holdings %
Top 10 Hldgs %
50%
Holding
73
New
21
Increased
14
Reduced
9
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$46.9M |
| 2 |
Viatris
VTRS
|
+$32.7M |
| 3 |
RDUS
Radius Health, Inc.
RDUS
|
+$30.7M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$29.4M |
| 5 |
Coherus Oncology
CHRS
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDR
McDermott International
MDR
|
+$27.1M |
| 2 |
CZR
Caesars Entertainment Corporation
CZR
|
+$22.7M |
| 3 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
+$22.1M |
| 4 |
GMS
GMS Inc
GMS
|
+$20.5M |
| 5 |
Builders FirstSource
BLDR
|
+$18.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.37% |
| 2 | Financials | 17.17% |
| 3 | Technology | 9.55% |
| 4 | Consumer Discretionary | 7.08% |
| 5 | Materials | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Heron Therapeutics
HRTX
$95M
| $72.3M | 8.95% |
2,787,592
+828,742
| +42% | +$22.8M |
|
|
COOP
2
DELISTED
Mr. Cooper
COOP
| $47.8M | 5.92% |
4,100,000
+38,935
| +1% | +$556K |
|
|
BRSL
3
Brightstar Lottery PLC
BRSL
$2.08B
| $43.9M | 5.43% |
3,000,000
-850,000
| -22% | -$14.1M |
|
4
Incyte
INCY
$24.3B
| $42.9M | 5.31% |
675,000
-119,640
| -15% | -$7.77M |
|
|
ZAYO
5
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $39.1M | 4.84% |
+1,713,800
| New | +$46.9M |
|
|
RDUS
6
DELISTED
Radius Health, Inc.
RDUS
| $34.6M | 4.29% |
2,100,000
+1,822,740
| +657% | +$30.7M |
|
|
AVYA
7
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $32.8M | 4.06% |
2,254,151
+380,091
| +20% | +$6.45M |
|
8
Green Plains
GPRE
$1.16B
| $32.6M | 4.04% |
2,486,820
+236,820
| +11% | +$3.88M |
|
|
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $30.1M | 3.73% |
+814,357
| New | +$29.4M |
|
|
10
Viatris
VTRS
$20.5B
| $27.7M | 3.43% |
+1,010,000
| New | +$32.7M |
|
|
11
Coherus Oncology
CHRS
$224M
| $27.6M | 3.42% |
3,050,000
+2,420,000
| +384% | +$28M |
|
|
PRTY
12
DELISTED
Party City Holdco Inc.
PRTY
| $25.9M | 3.21% |
2,600,000
+1,095,000
| +73% | +$11.9M |
|
|
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $25.1M | 3.1% |
+643,397
| New | +$25.3M |
|
14
BGC Group
BGC
$5.18B
| $24.7M | 3.06% |
4,776,852
+2,288,852
| +92% | +$15.1M |
|
15
Assured Guaranty
AGO
$3.67B
| $22.1M | 2.74% |
577,836
+394,099
| +214% | +$15.7M |
|
16
MBIA
MBI
$270M
| $21.5M | 2.66% |
2,411,400
+400,000
| +20% | +$3.81M |
|
17
WillScot Mobile Mini Holdings
WSC
$4.81B
| $20.5M | 2.53% |
2,171,738
-578,262
| -21% | -$8.19M |
|
|
AERI
18
DELISTED
Aerie Pharmaceuticals
AERI
| $20.3M | 2.51% |
+562,185
| New | +$26.4M |
|
19
Magnachip Semiconductor
MX
$134M
| $18.6M | 2.31% |
3,000,000
| – | – |
|
|
AMRN
20
Amarin Corp
AMRN
$303M
| $18.3M | 2.27% |
67,269
+32,269
| +92% | +$11.8M |
|
21
Constellium
CSTM
$4.02B
| $14.2M | 1.75% |
2,024,600
-383,358
| -16% | -$3.41M |
|
|
SMTA
22
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
| $13.1M | 1.63% |
1,841,587
| – | – |
|
23
Hilton Grand Vacations
HGV
$3.66B
| $12.9M | 1.59% |
+487,220
| New | +$14.1M |
|
24
Teva Pharmaceuticals
TEVA
$40.4B
| $12.8M | 1.58% |
+830,000
| New | +$17M |
|
25
Flex
FLEX
$45B
| $12.8M | 1.58% |
+2,227,961
| New | +$15.6M |
|
Similar funds
SCM
RCM
SIM
NPT
AC
PVI
WPL
BAMF
Rubric Capital Management (New York)'s Q4 2018 Portfolio in Review
As of Q4 2018, Rubric Capital Management (New York) held 73 positions worth $808M, down 15% from $946M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Rubric Capital Management (New York) deployed $114M of net new capital in Q4 2018, opening 21 new positions and adding to 14 existing holdings. Its largest new stake was Zayo Group Holdings, Inc.: 1,713,800 shares worth $39.1M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Flexion Therapeutics, Inc., an estimated $22.1M trimmed.
- Rubric Capital Management (New York)'s largest Q4 2018 buy was Zayo Group Holdings, Inc.: 1,713,800 shares worth $39.1M.
- Rubric Capital Management (New York) added most to Radius Health, Inc. in Q4 2018, an estimated $30.7M increase.
- Rubric Capital Management (New York)'s biggest Q4 2018 reduction was Flexion Therapeutics, Inc., cutting an estimated $22.1M.
- Rubric Capital Management (New York) fully exited McDermott International in Q4 2018, selling an estimated $27.1M.
- Rubric Capital Management (New York)'s ten largest holdings make up 50% of its $808M portfolio in Q4 2018.
- Rubric Capital Management (New York) opened 21 new positions and closed 24 in Q4 2018.
- Rubric Capital Management (New York)'s portfolio value fell 15% quarter-over-quarter to $808M.
Based on Rubric Capital Management (New York)'s 13F filing for Q4 2018, filed 13 Feb 2019.